TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
CYTK

Cytokinetics Inc

Healthcare · Biotechnology

61.40$ -2.2% vs. previous close Closing price · As of: Oct 6, 2026

Statements

Balance Sheet

Cytokinetics Inc (CYTK) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,925 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CYTK
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
158 170 265 341 326 295 280 247 230 211 199 198 187 290 257 232 474 534 577 564 828 841 856 772 1,076 1,015 890 780 741 824 808 1,524 1,436 1,402 1,264 1,226 1,437 1,425 1,273 1,925
148 159 211 317 322 274 272 244 227 208 186 185 177 234 226 219 418 474 433 364 495 536 624 602 884 795 681 587 561 628 639 1,068 1,019 1,108 956 887 977 917 839 1,208
30 67 49 101 116 125 115 47 28 42 39 34 40 36 50 61 201 83 45 37 91 113 115 94 106 66 102 69 100 113 120 191 47 95 74 75 225 123 130 255
79 156 207 312 308 269 251 232 210 199 177 173 166 225 221 213 410 464 426 350 478 472 609 586 868 783 664 566 539 615 619 1,057 1,012 1,076 938 858 963 882 819 1,166
67 0.0 0.9 – 10 1.1 19 11 15 6.8 6.6 9.6 6.6 5.2 2.7 2.3 5.0 4.4 4.5 2.7 0.6 52 6.1 2.0 2.3 0.1 1.0 1.0 2.5 1.3 0.8 0.0 0.2 17 2.0 8.4 1.8 18 6.8 24
0.0 0.0 0.0 0.0 0.0 0.0 -19 -11 -15 -6.8 0.0 -9.6 -6.6 – 0.0 -2.3 -5.0 -4.4 – 0.0 -0.6 -52 -6.1 -2.0 0.0 -0.1 -1.0 -1.0 -2.5 – -0.8 – -0.2 – – – – – 0.2 0.4
2.0 3.6 3.5 3.3 3.3 3.6 3.2 2.6 2.7 3.2 3.2 2.9 3.6 4.5 5.2 5.6 7.7 13 23 120 54 73 76 79 80 80 79 158 – – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
75 76 170 166 179 185 180 172 178 185 195 203 207 301 302 311 325 420 509 548 579 597 740 660 1,092 1,123 1,119 1,113 1,179 1,211 1,204 1,415 1,450 1,537 1,530 1,594 1,958 2,084 2,100 2,098
29 33 37 31 42 32 39 27 21 22 26 22 22 26 21 23 28 31 36 62 81 72 67 67 76 85 75 66 78 103 89 103 110 180 160 131 142 202 199 181
0.7 2.5 4.8 7.3 9.8 5.3 28 1.7 3.8 2.6 15 4.5 4.6 4.6 5.0 5.1 3.9 2.8 11 23 30 15 14 14 16 14 14 16 17 28 30 30 30 30 33 34 38 60 66 48
0.7 4.2 3.0 1.8 4.1 5.3 2.4 1.3 2.0 3.8 2.5 5.2 3.4 8.2 3.5 2.9 6.7 8.1 7.8 15 16 21 20 14 14 26 17 13 14 22 13 9.5 12 20 14 16 22 22 25 21
30 27 25 23 20 32 32 31 38 40 36 44 45 45 45 46 46 46 41 128 30 47 61 62 64 64 64 610 609 607 607 643 644 646 645 713 1,048 1,116 1,118 1,120
83 94 95 175 147 110 100 75 52 26 3.4 -4.9 -20 -11 -46 -78 150 113 68 16 249 244 116 111 -16 -108 -229 -333 -439 -386 -396 109 -14 -135 -266 -369 -521 -660 -827 -173
-527 -518 -544 -573 -606 -646 -658 -688 -714 -743 -773 -805 -834 -865 -904 -945 -948 -992 -1,039 -1,101 -1,177 -1,208 -1,286 -1,306 -1,449 -1,586 -1,717 -1,846 -1,975 -2,112 -2,248 -2,391 -2,552 -2,702 -2,863 -2,998 -3,304 -3,487 -3,693 -3,892
43 44 42 48 54 54 54 54 55 55 55 58 59 59 59 60 68 71 71 72 80 84 85 86 94 95 95 96 96 99 102 109 118 118 118 119 120 122 123 132

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?